Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 10

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
Studies in experimental stroke demonstrate that cerebral ischemic injury promotes neurogenesis in the subventricular zone (SVZ) and subgranular zone (SGZ) of the dentate gyrus. Spontaneously occurring injury-induced neurogenesis is insufficient to fully reverse disease pathophysiology. Exogenous neural progenitors transplanted into damaged brain might be useful for facilitating the repair of damaged tissue by instructing several endogenous processes. However, the molecular and cellular mechanisms stimulating cell proliferation and mediating the migration of arising neuroblasts towards the ischemic boundary still remain to be characterized. Building evidence suggests that matrix metalloproteinases (MMPs) seem to play a role in neurogenesis-associated processes, providing an environment which may be instructive or permissive to stem cells activation. The overall goal of our present studies was to examine whether HUCB-NSC transplantation modulates migration of endogenous progenitor cells and MMPs activity in adult rat brain after focal ischemia. Methods: 2x104 neural stem cells from human cord blood (HUCB-NSC) were transplanted into corpus callosum of naive or focally injured (induced by 1µl/50nmol OUA injection) rat brain. At 1, 3, 7 and 14 days rat brains were removed. Then immunocytochemical analysis of doublecortin (DCX) (marker expressed by immature migratory neuroblasts) and in situ zymography of MMPs activity was performed. Results: OUA-induced brain lesion resulted in increase of DCX+ cells in SVZ and SGZ in comparison to intact rats. This response has been potentiated by HUCBNSC transplantation. Moreover, the activation of MMPs in cells was visible in SVZ. At 7th day after HUCB-NSC transplantation the intense migration of DCX+ cells from SVZ towards ischemic boundary regions of the striatum was observed. Double-labeling showed co-localization of DCX marker with MMPs activity. The presence of MMPs appeared to be associated with cell nuclei and cytoplasm but interestingly it was also seen outside the cell bodies and in the neuronal protrusions. Conclusions: Proteolytic activity of MMPs in extracellular compartment suggests its ability to remodel extracellular matrix and facilitate migration of neuroblasts to the damaged brain areas. The localization of MMPs in cell nuclei implies the involvement of these proteases in proteolytical activation of pro-neural gene transcription. Supported by MSHE grant no N401 014235.
Neural stem cells (NSC) are potentially a promising treatment strategy for neurological diseases. There is a proof that intracerebral grafting of NSC can have restorative effects. Nevertheless, a major obstacle is the induction of a host-derived immune response followed by graft injection. The goal of the study was to analyze the fate of HUCB-NSC transplanted in injured rat brain. Methods: 2×104 HUCB-NSC were tx into corpus callosum of a focal brain injury induced by OUA injection (1 μl/50 nmol) into striatum of adult Wistar rats. After 1, 3, 7 and 14 days brains were removed and analyzed immunocytochemically. Results. One day after HUCB tx, most cells remained in the injection site with few cells migrated to the lesion area. Concomitantly, infi ltration of ED1+ and CD15+ cells with occasional appearance of CD5+ and CD45+ cells was seen. At 3rd day some HUCB-NSC in graft core expressed neuronal (NF-200) or astrocytic (GFAP) markers. Migration of tx cells into the lesion was observed. At 7th day HUCB-NSC were found close to injured area. By 14 days, no viable HUCB-NSC have been noticed with cellular debris in graft core. Limited number of ED1+, CD15+, CD5+ and CD45+ cells were found most likely due to HUCB-NSC rejection. Conclusions. Massive loss of transplanted HUCB-NSC was probably due to post traumatic infl ammation and acute immune reaction of the host in term of cross-species grafting paradigm. Supported by MSHE grant N401 014235 and Fondation Jerome Lejeune scientifi c grant.
There is a great interest in the possibility of repairing the nervous system by transplantation new cells that can replace those lost through damage in neurological disorders. Key functions such as the replacement of neural cells have been recently challenged by intrinsic bystander capacities of undifferentiated donor cells to restore these cells. A comprehensive knowledge how transplanted stem cells exert their therapeutic achievements is still lacking. Here we investigated the effects of HUCB-NSC infused into the damaged rat brain at 72 h post ischemia on endogenous neurogenesis. The goal of our studies was to examine the proliferation and migration of host progenitor cells, analyze the substantial matrix remodeling of tissue and the presence of neurotrophic factors in rat brain after focal ischemia followed by HUCB-NSC transplantation. Methods: 2×104 HUCB-NSC were transplanted into corpus callosum of naive or focally injured rat brain 3 days after ischemic insult. At 1, 3, 7 and 14 days rat brains were removed. Endogenous cell proliferation was determined by BrdU incorporation. Then immunocytochemical analysis of doublecortin (DCX) and PSA-NCAM (markers expressed by immature migratory neuroblasts), and in situ zymography of MMPs activity was performed. Additionally, total RNA was isolated from rat brain tissue and RTPCR was performed using sets of primers of each of human and rat neurotrophic factor genes. Results: OUA-induced brain lesion resulted in increase of proliferating (BrdU+) and migrating (DCX+ and PSA-NCAM+) cells in subventricular zone (SVZ) and subgranular zone (SGZ) regions in comparison to intact rats. This response has been potentiated by HUCB-NSC transplantation. At 7th day after HUCB-NSC infusion the intense migration of DCX+cells from SVZ towards ischemic boundary regions of the striatum was observed. Moreover, the activation of MMPs in cells was visible in SVZ. Double-labeling showed co-localization of DCX marker with MMPs activity. The presence of MMPs appeared to be associated with cell nuclei and cytoplasm but interestingly it was also seen outside the cell bodies and in the neuronal protrusions. In OUAinduced lesion rat brain tissue, the expression pattern of rat-origin neurotrophic factors mRNA was higher than in intact rats. HUCBNSC transplantation into focal brain ischemic tissue significantly increased mRNA expression of several rat-origin growth factors, such as GDNF, CNTF responsible for regulation of proliferation and maturation of stem cells as well as IGF-1, HGF and presaposin functioning as anti-apoptotic mediators. The significant increment was observed 7 days after HUCB-NSC infusion. Using Real Time PCR method we were able to detect the presence of mRNA of BDNF, GDNF, NT3, IGF-1, HGF, semaphorin and presaposin of human-origin factors in the rat brain recipients of HUCB-NSC grafts. Conclusions: Transplantation of HUCB-NSC triggers early expansion of endogenous progenitor pool increasing fraction of proliferating cells in SVZ and SGZ of brain ischemic rats. Proteolytic activity of MMPs in extracellular compartment suggests its ability to remodel extracellular matrix and facilitate migration of neuroblasts to the damaged brain areas. The mechanism promoting recovery from ischemic injury remains to be clarified, although it is likely that it might be due to HUCB-NSC graft-induced release of neurotrophic factors by the host cells as well as the presence of human neural stem cells derived factors. Supported by MMRC statutory fund.
Many types of neural progenitors from different sources have been tested for experimental therapy in CNS injuries. We have established neural stem cell line from human cord blood (HUCB-NSC). In vitro evidence has suggested that HUCB-NSC are not immunogenic however their transplantation (tx) into adult rats led to the graft cell rejection. The question arises what is the nature of the host immune response to transplanted HUCB-NSC? Methods: 2 × 104 HUCBNSC were tx into corpus callosum of a focal brain injury induced by OUA injection (1 μl/5 mmol) into striatum of adult Wistar rats. At 1, 3, 7 and 14 days thereafter brains were removed and immunocytochemical analysis for T cells (CD5), B cells (CD45), macrophages (ED1) and neutrophils (CD15) was performed. Results: One day after HUCB-NSC tx, most cells remained in the injection site and only few cells migrated to the lesion area. Concomitantly, infi ltration of ED1+ and CD15+ cells with occasional appearance of CD5+ and CD45+ cells was seen around the graft and close to the lesion. At 3rd day after HUCB-NSC tx, the infi ltrate of ED1+ cells increased however, the number of CD15+, CD5+ and CD45+ cells stayed unchanged. At 7th day after HUCB-NSC tx, the number of ED1+ and CD15+ cells was reduced dramatically compare to the 3rd day and only single CD5+ and CD45+ cells were observed. By 14 days, limited number of ED1+, CD15+, CD5+ and CD45+ cells were found most likely due to the scar formation and rejection of HUCB-NSC. At that time no viable HUCB-NSC have been noticed in brain tissue of the host Conclusion: Transfer of HUCB-NSC into ouabain induced brain lesion rats elicits innate (macrophages/neutrophils) and adaptive (T/B lymphocytes) immune response in the acute phase post-transplantation. Supported by MSHE grant No 142/P01/2008/35
Stem cell transplantation offers an exciting new therapeutic avenue for stroke not only to prevent damage, which has been the focus of conventional therapeutic strategies, but also to actually repair the injured brain. Indeed, exogenous stem cell grafting in animal models of CNS damage improves function by replacing the lost neurons. However, therapeutic mechanism different from the expected contribution of cell replacement have been also postulated. Many studies applying systemic delivery of cells in ischemic stroke disorders have shown significant functional recovery with very few or frequently no cells entering brain. It seems that transplanted cells could propel local micro-environmental signals to sustain active endeavors for damaged neurons substitution. The question arises if systemic infusion of cells enhances endogenous neurogenesis previously activated by focal ischemic brain injury. Materials and methods: Experimental model of focal ischemic brain injury was performed by local application of Na/K ATP-ase pump inhibitor - ouabain (OUA) (1 µl/50nmol) into the striatum of CsA-immunosuppressed adult Wistar rats. Three days later 107 human umbilical cord blood CD34- mononuclear cells (HUCB-MNC) were infused into internal carotic artery. At 30 day thereafter rat brains were removed and the neurogenic regions and tissue around the damaged areas were analyzed immunohistochemically. Results: Analysis of brain tissue in OUA injured rats transplanted with HUCB-MNC revealed augmentation of proliferative cells (Ki-67+) in subventricular zone (SVZ) of ipsilateral hemisphere and at the border of the lesion area as well as higher number of DCX+ cells in SVZ. Moreover, the extensive neuroblast migration and their accumulation in the perinfarct striatum were observed in comparison to non-transplanted rats after OUA injury onset. HUCB-MNC injection into rats with brain infarct showed a significant increase of cells with immature (Nestin+) or more mature (NF-200+) neuronal phenotypes observed in the tissue alongside OUA lesion. The intensive staining of GFAP at the border of injured area in HUCB-MNC transplanted and nontransplanted rats reflected gliosis however, the increased expression of GFAP in brain tissue of the former ones may point to the possible expansion of endogenous progenitors. In conclusions, HUCB-MNC transplanted systemically into OUA focal ischemic brain injured rats activate the endogenous stem cell compartment where the newly arisen cells adopt a neuronal or astrocytic fate. This effect may prove applicable for future clinical therapy. Supported by MSHE grants: 0142/B/P01/2008/35 and 0394/B/ P01/2010/38
Transplantation (tx) of neural stem cells (NSC) is the key strategy of cell replacement therapy in the central nervous system. The goal of the study was to compare survival, migration and differentiation of HUCB-NSC after their tx into the brain of neonatal and adult Wistar rats. Methods: HUCB-NSC (2 × 104 ) labeled with CMFDA were tx into SVZ of the postnatal day 0 (P0) rats or into intact brain of adult rats. After 1, 3, 7, 14 or 21 days brains were removed, frozen and cut into 20 μm coronary slices, then immunohistochemical studies were performed to visualize HUCB-NSC fate in the brain. Results: In neonatal rats, 3 days after tx most of HUCB-NSC remained in the graft. During the fi rst week HUCB-NSC started to disperse and migrate. HUCB-NSC situated at the periphery of the graft or in migratory stream display proliferation marker (Ki67). After 7ñ21 days HUCB-NSC survived in the host brain with many cells expressing neuronal or astrocytic phenotypes. Few of HUCB-NSC presented the features of adult neurons (MAP2+ with long protrusions). In adult rats, 3 days after tx, HUCB-NSC form dense deposit with single cells migrating into brain tissue. Most of the HUCB-NSCs stayed undifferentiated with few cells expressing neuronal (NF200) or astrocytic (GFAP) markers. After 7 days numerous HUCB-NSC situated inside the graft underwent degeneration and subsequent depletion. Tx HUCB-NSC induced infl ammatory response detected by macrophage/microglia (ED1+) accumulation and astrogliosis (GFAP+). No viable HUCB-NSC were found after 14 days. Conclusions: Host environment dictates the fate of tx neural stem cells derived from human cord blood however immunological response in adult rats limits the time of observation due to short survival of HUCB-NSC. Supported by MSHE grant no 2PO5A05430
Mesenchymal stem cell (MSC) transplantation offers new therapeutic avenue for neurological diseases, however limitted survival of exogenous cells in the host brain is a major setback. The aim of this study was to evaluate the efficacy of using biodegradable scaffolds or Wharton jelly implants contained MSC after their transplantation into rat brain.Materials and methods: Adult Wistar rats were transplanted with MSC derived from human umbilical cord (hUC-MSC) (i), hUC-MSC localized inside biodegradable gelatin/laminin scaffolds (hUC-MSC/GL) (ii) or Wharton jelly implants (hUC-MSC/WJ) (iii). Results: hUC-MSC cultured in vitro expressed CD73, CD90, CD166 and Oct3/4, Nanog1, Nestin markers. 7 days after hUC-MSC transplantation only few viable donor cells were observed in the rat brain surrounded by heavy infiltration of macrophages/microglia (ED1+) and activating astrocytes (GFAP+). Hence transplantation of hUC-MSC/GL resulted with better cell survival compared with hUCMSC grafted in suspension. There was no donor cell migration out of the scaffolds however hUC-MSC lodged inside G/L scaffolds attained early neural markers. The inflammatory cell influx observed around the scaffolds was less intense with few ED1+ cells present in the core of scaffold. Similarly, all transplanted hUC-MSC/WJ remained in 3D tissue implants. Some of these cells adopted NF200, A2B5 or GFAP phenotypes during 7 days of observation. Concomitantly only scarce infiltration of immunoreactive cells was seen. Conclusions: Transplantation of hUC-MSC in 3D G/L scaffolds or hUC-MSC/WJ implants into adult rat brain improves survival of donor cells and induces their spontaneous transition into cell of neural lineage. It seems that 3D structures protect cells localized inside them from the host immune cells and may allow the diffusion of nutrients and other factors to propagate cell survival and differentiation into neuronal lineage. Supported by MSHE grant no N401 014235 and Fondation Jerome Lejeune grant.
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.